HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Travis K Warren Selected Research

Marburg Virus Disease

11/2020Remdesivir (GS-5734) Is Efficacious in Cynomolgus Macaques Infected With Marburg Virus.
2/2016Delayed Time-to-Treatment of an Antisense Morpholino Oligomer Is Effective against Lethal Marburg Virus Infection in Cynomolgus Macaques.
4/2014Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.
11/2012Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Travis K Warren Research Topics

Disease

17Infections
01/2021 - 05/2010
7Ebola Hemorrhagic Fever
01/2021 - 05/2009
4Marburg Virus Disease
11/2020 - 11/2012
3Filoviridae Infections
01/2018 - 05/2010
2Body Weight (Weight, Body)
02/2016 - 07/2015
2Viremia
02/2016 - 05/2010
2Viral Hemorrhagic Fevers (Viral Hemorrhagic Fever)
06/2013 - 09/2010
2Smallpox (Variola)
04/2008 - 02/2008
1Melioidosis
01/2019
1Bacterial Infections (Bacterial Infection)
01/2018
1Necrosis
01/2018
1Vascular System Injuries
01/2018
1Gaucher Disease (Gaucher's Disease)
01/2017
1Dengue (Dengue Fever)
01/2017
1Human Influenza (Influenza)
01/2017
1Inflammation (Inflammations)
11/2014
1Virus Diseases (Viral Diseases)
04/2014
1Primate Diseases
04/2014
1Fever (Fevers)
06/2013
1Vaccinia
02/2008

Drug/Important Bio-Agent (IBA)

8Antiviral Agents (Antivirals)IBA
12/2018 - 05/2010
6VaccinesIBA
11/2014 - 02/2008
4MorpholinosIBA
02/2016 - 05/2009
3AVI-7288IBA
02/2016 - 11/2012
2remdesivirIBA
01/2021 - 11/2020
2Proteins (Proteins, Gene)FDA Link
11/2019 - 01/2019
2favipiravirIBA
01/2018 - 01/2018
2CytokinesIBA
02/2016 - 05/2010
2Pharmaceutical PreparationsIBA
07/2015 - 06/2013
1AerosolsIBA
01/2021
1Monoclonal AntibodiesIBA
01/2020
1Peptides (Polypeptides)IBA
11/2019
1CholesterolIBA
11/2019
1Complement System Proteins (Complement)IBA
01/2019
1Blood Proteins (Serum Proteins)IBA
01/2019
1Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2019
1ProteomeIBA
01/2019
1Anti-Bacterial Agents (Antibiotics)IBA
01/2018
1AntigensIBA
01/2018
1Viral RNAIBA
01/2018
1miglustat (Zavesca)FDA Link
01/2017
1NucleoproteinsIBA
02/2016
1Azithromycin (Zithromax)FDA LinkGeneric
07/2015
1galidesivirIBA
04/2014
1Adenosine (Adenocard)FDA LinkGeneric
04/2014
1GlucosidasesIBA
06/2013
1SugarsIBA
06/2013
1Imino SugarsIBA
06/2013
1Viral ProteinsIBA
04/2013
1Glycoproteins (Glycoprotein)IBA
04/2013
1InosineFDA Link
04/2012
1FGI 103IBA
05/2010
1Smallpox Vaccine (Vaccine, Smallpox)FDA Link
04/2008
1Neutralizing AntibodiesIBA
02/2008
1tecovirimatIBA
02/2008

Therapy/Procedure

9Therapeutics
01/2021 - 09/2010
1Anesthesia
01/2018
1Catheters
01/2018
1Aftercare (After-Treatment)
07/2017
1Enteral Nutrition (Feeding, Tube)
01/2017
1Time-to-Treatment
02/2016
1Treatment Delay
02/2016